Who is sponsoring NCT03985579?

NCT03985579 is sponsored by Żelazna Medical Centre, LLC.

What drugs are being tested in NCT03985579?

Interventions in NCT03985579: Kinesiology taping application.

What condition does NCT03985579 study?

NCT03985579 studies Lactation Disorders.

Is NCT03985579 still recruiting?

NCT03985579 is currently status unknown. Last updated 6 August 2020.

Last reviewed 2020-08-06 · How we verify

NCT03985579

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Influence of Kinesiology Taping Application on Severity of Signs and Symptoms in Breast Engorgement.

Status unknown NA Last updated 6 August 2020

What this trial tests

NA trial testing Kinesiology taping application in Lactation Disorders in 60 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
1 September 2020

1 December 2020

Quick facts

Lead sponsor	Żelazna Medical Centre, LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	60
Start date	1 July 2019
Primary completion	1 September 2020
Estimated completion	1 December 2020
Sites	1 location across Poland

Drugs / interventions tested

Kinesiology taping application

Conditions studied

Lactation Disorders — all drugs for Lactation Disorders →

Sponsor

Żelazna Medical Centre, LLC

Who can join

Adults 18 to 45, female only, with Lactation Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the research is to asses the efficacy of kinesiology taping application in breast engorgement in early postpartum stage. Kinesiology application will be performed by women's health physiotherapist. Patient's perceived improvement and milk outflow following application will be assessed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatments for breast engorgement during lactation.
Zakarija-Grkovic I, Stewart F. · · 2020 · cited 20× · PMID 32944940 · DOI 10.1002/14651858.cd006946.pub4

Verify or expand the search:

Other Żelazna Medical Centre, LLC trials

Trials by the same sponsor.

NCT07154576 — Central Sensitization Inventory and Symptoms of Pelvic Floor Dysfunctions · enrolling by invitation
NCT05004402 — Pelvic Floor Muscle Function, Pelvic Floor Dysfunction and Diastasis Recti Abdominis in Postpartum Women · completed
NCT04813237 — Clinical Implications of Fetal Positioning During Delivery · unknown
NCT04757077 — The Association Between Pelvic Floor Muscle Function, Diastasis Recti and Postpartum Pelvic Girdle Pain - a Matched Case · completed
NCT05318989 — Genetic Aspects of Vaginal Aging · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03985579 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Żelazna Medical Centre, LLC
Last refreshed: 6 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03985579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing